Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
Danish Medicines Council, Dampfærgevej 27-29, 2100 Copenhagen, Denmark.
Cells. 2020 Jan 16;9(1):223. doi: 10.3390/cells9010223.
Over 90% of cancer deaths are due to cancer cells metastasizing into other organs. Invasion is a prerequisite for metastasis formation. Thus, inhibition of invasion can be an efficient way to prevent disease progression in these patients. This could be achieved by targeting the molecules regulating invasion. One of these is an oncogenic transcription factor, Myeloid Zinc Finger 1 (MZF1). Dysregulated transcription factors represent a unique, increasing group of drug targets that are responsible for aberrant gene expression in cancer and are important nodes driving cancer malignancy. Recent studies report of a central involvement of MZF1 in the invasion and metastasis of various solid cancers. In this review, we summarize the research on MZF1 in cancer including its function and role in lysosome-mediated invasion and in the expression of genes involved in epithelial to mesenchymal transition. We also discuss possible means to target it on the basis of the current knowledge of its function in cancer.
超过 90%的癌症死亡是由于癌细胞转移到其他器官。侵袭是转移形成的前提。因此,抑制侵袭可以成为预防这些患者疾病进展的有效方法。这可以通过靶向调节侵袭的分子来实现。其中之一是致癌转录因子,髓样锌指 1(MZF1)。失调的转录因子代表了一组独特且不断增加的药物靶点,这些靶点负责癌症中异常基因表达,是推动癌症恶性的重要节点。最近的研究报告称,MZF1 在各种实体癌的侵袭和转移中起着核心作用。在这篇综述中,我们总结了关于 MZF1 在癌症中的研究,包括其在溶酶体介导的侵袭以及上皮间质转化相关基因表达中的功能和作用。我们还根据目前对其在癌症中的功能的了解,讨论了靶向它的可能方法。